HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
KCLB Cat# 10002, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
KCLB |
10002 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-07-25 04:40:44 |
39012 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
Abcam Cat# ab271142, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569
PMID:1246620
PMID:1522048
PMID:2983228
PMID:2990217
PMID:3028716
PMID:3180844
PMID:3371749
PMID:3518877
PMID:4942173
PMID:5668122
PMID:6256643
PMID:6358339
PMID:6401685
PMID:6825208
PMID:6935474
PMID:8380785
PMID:9892199
PMID:10423141
PMID:11416159
PMID:11668190
PMID:12001993
PMID:12661003
PMID:12793746
PMID:13052828
PMID:13207312
PMID:13261081
PMID:14031339
PMID:14185313
PMID:15302935
PMID:15531914
PMID:15901131
PMID:16589695
PMID:16957166
PMID:17311676
PMID:19450234
PMID:19722756
PMID:19941903
PMID:21269460
PMID:21937730
PMID:22068331
PMID:22278370
PMID:22412903
PMID:23205564
PMID:23336012
PMID:23925224
PMID:23925245
PMID:24134916
PMID:24618588
PMID:24696503
PMID:24908793
PMID:25485619
PMID:25807930
PMID:25877200
PMID:25894527
PMID:25960936
PMID:26554430
PMID:26589293
PMID:27397505
PMID:28078501
PMID:28196595
PMID:28261610
PMID:28601559
PMID:29156801
PMID:30175587
PMID:30778230
PMID:30787054
PMID:30894373
PMID:31068700
PMID:31433507
PMID:31790455
PMID:33389257
PMID:35198691
PMID:35839778
PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
Abcam |
ab271142 |
BTO:BTO_0000567,
CLO:CLO_0003684,
CLO:CLO_0050910,
EFO:EFO_0001185,
MCCL:MCC:0000219,
CLDB:cl1594,
CLDB:cl1595,
CLDB:cl1596,
CLDB:cl1597,
CLDB:cl1599,
CLDB:cl1600,
CLDB:cl1601,
CLDB:cl1603,
Abcam:ab255448,
Abcam:ab255928,
Abcam:ab260075,
Abcam:ab271142,
Abcam:ab275466,
AddexBio:C0008001/44,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CCL-2,
ATCC:CRL-7923,
ATCC:CRM-CCL-2,
BCRC:60005,
BCRJ:0100,
BEI_Resources:ARP-153,
BioGRID_ORCS_Cell_line:95,
BioSample:SAMN03471148,
BioSample:SAMN03472333,
BioSample:SAMN10989629,
cancercelllines:CVCL_0030,
CCLV:CCLV-RIE 0082,
CCRID:1101HUM-PUMC000011,
CCRID:1101HUM-PUMC000332,
CCRID:1102HUM-NIFDC00057,
CCRID:3101HUMSCSP504,
CCRID:3101HUMTCHu187,
CCRID:4201HUM-CCTCC00009,
CCRID:5301HUM-KCB90024YJ,
CCTCC:GDC0009,
Cell_Model_Passport:SIDM00846,
ChEMBL-Cells:CHEMBL3308376,
ChEMBL-Targets:CHEMBL399,
CLS:300194,
Cosmic:760219,
Cosmic:760490,
Cosmic:801357,
Cosmic:809231,
Cosmic:877477,
Cosmic:911999,
Cosmic:925354,
Cosmic:928907,
Cosmic:944113,
Cosmic:1019309,
Cosmic:1057766,
Cosmic:1071911,
Cosmic:1131525,
Cosmic:1193029,
Cosmic:1201779,
Cosmic:1324208,
Cosmic:1336880,
Cosmic:1571796,
Cosmic:2301539,
Cosmic:2660190,
Cosmic:2750874,
Cosmic:2791019,
Cosmic:2816214,
Cosmic-CLP:1298134,
dbGAP:phs000640.v4.p1,
DepMap:ACH-001086,
DSMZ:ACC-57,
DSMZCellDive:ACC-57,
ECACC:93021013,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
EGA:phs000640,
FCS-free:44-2-47-1-8-9,
GDSC:1298134,
GEO:GSM113863,
GEO:GSM226739,
GEO:GSM226875,
GEO:GSM253298,
GEO:GSM436128,
GEO:GSM436129,
GEO:GSM501788,
GEO:GSM722574,
GEO:GSM722575,
GEO:GSM723055,
GEO:GSM723056,
GEO:GSM1088663,
GEO:GSM1088664,
GEO:GSM1088665,
GEO:GSM1088666,
GEO:GSM1374528,
GEO:GSM1669875,
GEO:GSM1881473,
GEO:GSM1881474,
GEO:GSM1881475,
GEO:GSM7701367,
GEO:GSM7701368,
Hysigen:TCH-C193,
ICLC:HTL95023,
IGRhCellID:HeLA,
IZSLER:BS TCL 20,
JCRB:JCRB9004,
KCB:KCB 86019YJ,
KCB:KCB 90024YJ,
KCLB:10002,
LINCS_HMS:50061,
LINCS_LDP:LCL-1512,
Lonza:51,
MeSH:D006367,
NCBI_Iran:C115,
PharmacoDB:HeLa_536_2019,
PRIDE:PRD000007,
PRIDE:PRD000032,
PRIDE:PRD000123,
PRIDE:PRD000124,
PRIDE:PRD000345,
PRIDE:PRD000376,
PRIDE:PRD000525,
PRIDE:PRD000526,
PRIDE:PRD000527,
PRIDE:PXD000013,
PRIDE:PXD000243,
PRIDE:PXD000252,
PRIDE:PXD000279,
PRIDE:PXD000396,
PRIDE:PXD000474,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD000680,
PRIDE:PXD000759,
PRIDE:PXD000883,
PRIDE:PXD000895,
PRIDE:PXD000900,
PRIDE:PXD000953,
PRIDE:PXD000954,
PRIDE:PXD000999,
PRIDE:PXD001047,
PRIDE:PXD001118,
PRIDE:PXD001154,
PRIDE:PXD001175,
PRIDE:PXD001249,
PRIDE:PXD001258,
PRIDE:PXD001259,
PRIDE:PXD001278,
PRIDE:PXD001305,
PRIDE:PXD001374,
PRIDE:PXD001381,
PRIDE:PXD001396,
PRIDE:PXD001441,
PRIDE:PXD001541,
PRIDE:PXD001548,
PRIDE:PXD001574,
PRIDE:PXD001660,
PRIDE:PXD001781,
PRIDE:PXD001798,
PRIDE:PXD001805,
PRIDE:PXD001806,
PRIDE:PXD001810,
PRIDE:PXD001863,
PRIDE:PXD001907,
PRIDE:PXD002001,
PRIDE:PXD002039,
PRIDE:PXD002066,
PRIDE:PXD002252,
PRIDE:PXD002277,
PRIDE:PXD002378,
PRIDE:PXD002383,
PRIDE:PXD002395,
PRIDE:PXD002572,
PRIDE:PXD002591,
PRIDE:PXD002704,
PRIDE:PXD002844,
PRIDE:PXD002880,
PRIDE:PXD003186,
PRIDE:PXD003209,
PRIDE:PXD003258,
PRIDE:PXD003370,
PRIDE:PXD003503,
PRIDE:PXD003530,
PRIDE:PXD003560,
PRIDE:PXD003792,
PRIDE:PXD003813,
PRIDE:PXD003909,
PRIDE:PXD003913,
PRIDE:PXD003917,
PRIDE:PXD003924,
PRIDE:PXD004182,
PRIDE:PXD004271,
PRIDE:PXD004273,
PRIDE:PXD004452,
PRIDE:PXD004613,
PRIDE:PXD004736,
PRIDE:PXD004900,
PRIDE:PXD004914,
PRIDE:PXD004933,
PRIDE:PXD004934,
PRIDE:PXD004940,
PRIDE:PXD004995,
PRIDE:PXD005018,
PRIDE:PXD005107,
PRIDE:PXD005181,
PRIDE:PXD005346,
PRIDE:PXD005349,
PRIDE:PXD005366,
PRIDE:PXD005466,
PRIDE:PXD005509,
PRIDE:PXD005572,
PRIDE:PXD005712,
PRIDE:PXD005955,
PRIDE:PXD006112,
PRIDE:PXD006293,
PRIDE:PXD012045,
PRIDE:PXD012188,
PRIDE:PXD013064,
PRIDE:PXD023271,
PRIDE:PXD023835,
PRIDE:PXD027504,
PRIDE:PXD029773,
PRIDE:PXD030304,
Progenetix:CVCL_0030,
PubChem_Cell_line:CVCL_0030,
RCB:RCB0007,
RCB:RCB3680,
SKY/M-FISH/CGH:5351,
TKG:TKG 0331,
TOKU-E:1434,
Ubigene:YC-A012,
Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-07-25 04:40:43 |
39012 |
Hep-G2/C3A
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1098
|
Homo sapiens (Human)
|
Hepatoblastoma
|
Virology: Susceptible to infection by Zika virus (ZIKV) (PubMed=29468137)., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:12068308
PMID:20164919
PMID:20215515
PMID:22460905
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:29468137
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Male |
HepG2/C3A, Hep G2/C3A, C3A |
|
|
BTO:BTO_0003586,
CLO:CLO_0002119,
EFO:EFO_0002121,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-3581,
ATCC:CRL-10741,
BCRC:60177,
BCRJ:0291,
BioSample:SAMN03473207,
BioSample:SAMN10987645,
cancercelllines:CVCL_1098,
Cell_Model_Passport:SIDM01237,
ChEMBL-Cells:CHEMBL3308377,
ChEMBL-Targets:CHEMBL1075402,
CLS:305891,
Cosmic:724820,
Cosmic:910850,
Cosmic:1995354,
Cosmic-CLP:910850,
DepMap:ACH-001021,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
FCS-free:10-2-11-3-4-4,
GDSC:910850,
GEO:GSM886899,
GEO:GSM887964,
GEO:GSM1669638,
IARC_TP53:21205,
IARC_TP53:27688,
IGRhCellID:C3A,
LINCS_LDP:LCL-1927,
PharmacoDB:C3A_156_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1098,
PubChem_Cell_line:CVCL_1098,
Ubigene:YC-C093,
Wikidata:Q54882789 |
cvcl_0027 |
|
CVCL_1098 |
2026-07-25 04:40:51 |
121 |
HLE
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1281
|
Homo sapiens (Human)
|
Adult hepatocellular carcinoma
|
Caution: TP53 mutation indicated incorrectly as being at c.747G>T in PubMed=8389256., Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: Liver Cancer Model Repository (LIMORE)., Part of: JFCR45 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:52570
PMID:1778766
PMID:7874267
PMID:8389256
PMID:8835345
PMID:9290701
PMID:9359923
PMID:10523694
PMID:12029633
PMID:12679910
PMID:15767549
PMID:20164919
PMID:20215515
PMID:20937217
PMID:22460905
PMID:23505090
PMID:23887712
PMID:25877200
PMID:27397505
PMID:28196595
PMID:30894373
PMID:31063779
PMID:31068700
PMID:31378681
PMID:32899426
PMID:35839778
|
Cancer cell line
|
Male |
|
|
|
BTO:BTO_0005987,
CLO:CLO_0009986,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473204,
cancercelllines:CVCL_1281,
Cell_Model_Passport:SIDM00064,
CGH-DB:9075-4,
ChEMBL-Cells:CHEMBL3308108,
ChEMBL-Targets:CHEMBL1075464,
Cosmic:907057,
Cosmic:945156,
Cosmic:1518230,
Cosmic:2023859,
Cosmic:2162526,
Cosmic-CLP:907057,
DepMap:ACH-001089,
EGA:EGAS00001000978,
GDSC:907057,
GEO:GSM827170,
GEO:GSM887084,
GEO:GSM888154,
GEO:GSM936757,
GEO:GSM1374537,
GEO:GSM1669884,
GEO:GSM2551566,
IARC_TP53:2008,
IARC_TP53:21373,
JCRB:JCRB0404,
LIMORE:HLE,
LINCS_LDP:LCL-1939,
PharmacoDB:HLE_548_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1281,
PubChem_Cell_line:CVCL_1281,
TOKU-E:3605,
Wikidata:Q54889847 |
|
|
CVCL_1281 |
2026-07-25 04:42:52 |
8 |
HMV-II
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1282
|
Homo sapiens (Human)
|
Vaginal melanoma
|
Characteristics: Pigmented., Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2166075
PMID:3361142
PMID:12068308
PMID:15467732
PMID:20164919
PMID:20215515
PMID:25877200
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Female |
HMV-2, HMVII, Human Melanoma Vagina-II |
|
|
BTO:BTO_0002918,
CLO:CLO_0003786,
CLO:CLO_0050086,
CLDB:cl1700,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BCRJ:0316,
BioSample:SAMN03472908,
cancercelllines:CVCL_1282,
Cell_Model_Passport:SIDM00291,
CGH-DB:9289-4,
ChEMBL-Cells:CHEMBL3308667,
ChEMBL-Targets:CHEMBL614826,
Cosmic:688044,
Cosmic:874383,
Cosmic:905203,
Cosmic:907058,
Cosmic:1007155,
Cosmic:1477417,
Cosmic:2230117,
Cosmic-CLP:907058,
DepMap:ACH-002040,
ECACC:92042701,
EGA:EGAS00001000978,
GDSC:907058,
GEO:GSM827367,
GEO:GSM1669886,
IARC_TP53:21375,
LINCS_LDP:LCL-1285,
PharmacoDB:HMVII_555_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1282,
PubChem_Cell_line:CVCL_1282,
RCB:RCB0777,
RCB:RCB3685,
TKG:TKG 0318,
Wikidata:Q54889975 |
|
|
CVCL_1282 |
2026-07-25 04:42:56 |
7 |
HN
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1283
|
Homo sapiens (Human)
|
Oral cavity squamous cell carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8985100
PMID:17390010
PMID:17719389
PMID:18423281
PMID:20164919
PMID:20215515
PMID:22460905
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:30894373
PMID:31068700
|
Cancer cell line
|
Male |
|
|
|
BTO:BTO_0004589,
CLO:CLO_0003788,
CLDB:cl1701,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473149,
cancercelllines:CVCL_1283,
Cell_Model_Passport:SIDM01061,
ChEMBL-Cells:CHEMBL3308742,
ChEMBL-Targets:CHEMBL1075465,
Cosmic:907059,
Cosmic-CLP:907059,
DepMap:ACH-001090,
DSMZ:ACC-417,
DSMZCellDive:ACC-417,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:907059,
GEO:GSM888158,
GEO:GSM1669887,
IARC_TP53:21376,
IARC_TP53:25037,
LINCS_LDP:LCL-1209,
PharmacoDB:HN_557_2019,
Progenetix:CVCL_1283,
PubChem_Cell_line:CVCL_1283,
Wikidata:Q54889984 |
|
|
CVCL_1283 |
2026-07-25 04:42:56 |
4 |
HO-1-N-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1284
|
Homo sapiens (Human)
|
Buccal mucosa squamous cell carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9290701
PMID:12738951
PMID:17599052
PMID:20164919
PMID:20215515
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
Ho-1-N-1, Ho-1-n-1, HO1-N-1, HO1-N1, HO1N1, Nakata-1 |
|
|
BTO:BTO_0005771,
CLO:CLO_0009945,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03472524,
cancercelllines:CVCL_1284,
Cell_Model_Passport:SIDM00592,
CGH-DB:372-2,
ChEMBL-Cells:CHEMBL3308743,
ChEMBL-Targets:CHEMBL1075466,
Cosmic:924111,
Cosmic:1118793,
Cosmic:1120708,
Cosmic:1530741,
Cosmic:1571801,
Cosmic:2266787,
Cosmic-CLP:924111,
DepMap:ACH-002244,
EGA:EGAS00001000978,
GDSC:924111,
GEO:GSM827187,
GEO:GSM1669888,
IARC_TP53:27171,
JCRB:JCRB0831,
LINCS_LDP:LCL-1204,
PharmacoDB:HO1N1_559_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1284,
PubChem_Cell_line:CVCL_1284,
Wikidata:Q54890082 |
|
|
CVCL_1284 |
2026-07-25 04:42:59 |
2 |
HOP-92
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1286
|
Homo sapiens (Human)
|
Lung non-small cell carcinoma
|
Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2041050
PMID:9331090
PMID:10700174
PMID:15748285
PMID:17088437
PMID:18277095
PMID:19372543
PMID:20164919
PMID:22068913
PMID:22347499
PMID:22384151
PMID:22628656
PMID:22961666
PMID:23856246
PMID:23933261
PMID:24279929
PMID:24670534
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27377824
PMID:27397505
PMID:27807467
PMID:28196595
PMID:30894373
PMID:31068700
PMID:31733513
PMID:35839778
PMID:38861359
|
Cancer cell line
|
Male |
HOP 92, HOP.92, HOP92, Hop92, Hopkins-92 |
|
|
BTO:BTO_0004085,
EFO:EFO_0006440,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03471631,
BioSample:SAMN10989594,
cancercelllines:CVCL_1286,
Cell_Model_Passport:SIDM00134,
ChEMBL-Cells:CHEMBL3308091,
ChEMBL-Targets:CHEMBL613889,
Cosmic:687783,
Cosmic:875856,
Cosmic:897510,
Cosmic:905973,
Cosmic:974290,
Cosmic:1044247,
Cosmic:1092604,
Cosmic:1146946,
Cosmic:1175862,
Cosmic:1305345,
Cosmic:1312330,
Cosmic:1995443,
Cosmic:1998446,
Cosmic-CLP:905973,
DepMap:ACH-000825,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:905973,
GEO:GSM2125,
GEO:GSM50212,
GEO:GSM50275,
GEO:GSM206508,
GEO:GSM274792,
GEO:GSM274826,
GEO:GSM434299,
GEO:GSM743451,
GEO:GSM750805,
GEO:GSM794405,
GEO:GSM799339,
GEO:GSM799402,
GEO:GSM846358,
GEO:GSM1153409,
GEO:GSM1153410,
GEO:GSM1178221,
GEO:GSM1178222,
GEO:GSM1178223,
GEO:GSM1181257,
GEO:GSM1181315,
GEO:GSM1669890,
GEO:GSM2124657,
IARC_TP53:18068,
IGRhCellID:HOP-92_02GEO,
LiGeA:CCLE_870,
NCI-DTP:HOP-92,
PharmacoDB:HOP92_562_2019,
PRIDE:PXD003539,
PRIDE:PXD005942,
PRIDE:PXD005946,
PRIDE:PXD030304,
Progenetix:CVCL_1286,
PubChem_Cell_line:CVCL_1286,
SKY/M-FISH/CGH:2810,
Wikidata:Q54890156 |
|
|
CVCL_1286 |
2026-07-25 04:43:00 |
2 |
HOS
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0312
|
Homo sapiens (Human)
|
Osteosarcoma
|
Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1385192
PMID:2233717
PMID:2463881
PMID:2823272
PMID:6954533
PMID:12645653
PMID:15150091
PMID:15289353
PMID:17981215
PMID:19787792
PMID:20164919
PMID:20215515
PMID:21519327
PMID:22460905
PMID:23144859
PMID:26320182
PMID:26351324
PMID:26589293
PMID:27397505
PMID:28196595
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
|
|
|
BTO:BTO_0003904,
CLO:CLO_0003795,
CLO:CLO_0050810,
EFO:EFO_0002196,
MCCL:MCC:0000205,
CLDB:cl1702,
CLDB:cl1706,
CLDB:cl7155,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-1543,
BCRC:60308,
BCRJ:0339,
BioSample:SAMN01821560,
BioSample:SAMN01821729,
BioSample:SAMN03471393,
BioSample:SAMN10987602,
cancercelllines:CVCL_0312,
CCRID:1101HUM-PUMC000038,
CCRID:4201HUM-CCTCC00333,
CCRID:5301HUM-KCB15015YJ,
CCTCC:GDC0251,
CCTCC:GDC0333,
Cell_Model_Passport:SIDM00806,
ChEMBL-Cells:CHEMBL3308811,
ChEMBL-Targets:CHEMBL614173,
ChEMBL-Targets:CHEMBL614736,
CLS:300449,
CLS:300468,
Cosmic:687928,
Cosmic:759899,
Cosmic:907060,
Cosmic:931037,
Cosmic:931910,
Cosmic:1044082,
Cosmic:1070840,
Cosmic:1074391,
Cosmic:1176621,
Cosmic:1529902,
Cosmic:2816208,
Cosmic-CLP:907060,
DepMap:ACH-000613,
ECACC:87070202,
EGA:EGAS00001000978,
GDSC:907060,
GEO:GSM170248,
GEO:GSM185087,
GEO:GSM185088,
GEO:GSM320827,
GEO:GSM827319,
GEO:GSM879208,
GEO:GSM887088,
GEO:GSM888159,
GEO:GSM1669891,
GEO:GSM1676300,
GEO:GSM1701635,
GEO:GSM1914984,
GEO:GSM1914985,
GEO:GSM1914986,
GEO:GSM1914987,
GEO:GSM1915023,
GEO:GSM1915024,
GEO:GSM2635315,
GEO:GSM2635316,
GEO:GSM5087472,
GEO:GSM5087473,
GEO:GSM5087474,
GEO:GSM5087475,
GEO:GSM5087476,
GEO:GSM5087477,
IARC_TP53:27020,
ICLC:HTL04003,
IGRhCellID:HOS,
IZSLER:BS TCL 69,
JCRB:IFO50106,
KCB:KCB 2015015YJ,
LiGeA:CCLE_703,
LINCS_LDP:LCL-1421,
PharmacoDB:HOS_563_2019,
PRIDE:PXD022868,
PRIDE:PXD030304,
Progenetix:CVCL_0312,
PubChem_Cell_line:CVCL_0312,
RCB:RCB0992,
Wikidata:Q54890160 |
|
|
CVCL_0312 |
2026-07-25 04:43:01 |
32 |
BV-173
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_0181
|
Homo sapiens (Human)
|
Chronic myelogenous leukemia, BCR-ABL1 positive
|
Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1720549
PMID:3098690
PMID:3332852
PMID:3856862
PMID:6572735
PMID:9680106
PMID:10071072
PMID:10576511
PMID:14504097
PMID:16523483
PMID:20164919
PMID:20215515
PMID:20809971
PMID:22460905
PMID:26589293
PMID:27397505
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:31160637
PMID:35839778
|
Cancer cell line
|
Male |
BV173 |
|
|
BTO:BTO_0004950,
CLO:CLO_0002052,
EFO:EFO_0002118,
MCCL:MCC:0000072,
CLDB:cl510,
CLDB:cl4968,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
BioSample:SAMN03473373,
BioSample:SAMN10988488,
cancercelllines:CVCL_0181,
CCTCC:GDC0607,
Cell_Model_Passport:SIDM00962,
ChEMBL-Cells:CHEMBL3308228,
ChEMBL-Targets:CHEMBL2366145,
CLS:300133,
Cosmic:798672,
Cosmic:910710,
Cosmic:922164,
Cosmic:994184,
Cosmic:996292,
Cosmic:998702,
Cosmic:999741,
Cosmic:1019833,
Cosmic:1026570,
Cosmic:1037734,
Cosmic:1070701,
Cosmic:1071881,
Cosmic:1127249,
Cosmic:1176600,
Cosmic:1191703,
Cosmic:1524792,
Cosmic-CLP:910710,
DepMap:ACH-000432,
DSMZ:ACC-20,
DSMZCellDive:ACC-20,
EGA:EGAS00001000978,
GDSC:910710,
GEO:GSM236779,
GEO:GSM236815,
GEO:GSM886895,
GEO:GSM887960,
GEO:GSM1374414,
GEO:GSM1669633,
IARC_TP53:21199,
ICLC:HTL99018,
IGRhCellID:BV173,
LiGeA:CCLE_631,
LINCS_LDP:LCL-1111,
Lonza:117,
PharmacoDB:BV173_148_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0181,
PubChem_Cell_line:CVCL_0181,
Wikidata:Q54798653 |
|
|
CVCL_0181 |
2026-07-25 04:22:18 |
4 |
C-4-I
Resource Report
Resource Website
Discontinued
|
ATCC Cat# CRL-7396, RRID:CVCL_2253
|
Homo sapiens (Human)
|
Human papillomavirus-related cervical squamous cell carcinoma
|
Virology: Contains a complete HPV18 genome., Population: Caucasian., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:77569
PMID:327080
PMID:560251
PMID:833871
PMID:2983228
PMID:2990217
PMID:3029760
PMID:3518877
PMID:5796380
PMID:6935474
PMID:7459858
PMID:12661003
PMID:13863218
PMID:14114965
PMID:15531914
PMID:20215515
PMID:27397505
PMID:29156801
PMID:30894373
PMID:35692560
PMID:35839778
|
Cancer cell line
|
Female |
C-4I, C-4 I, C-4-i, C4-I, C4-1, C4 I, C4I, C41, Hs 636.T, Hs 636 T |
ATCC |
CRL-7396 |
BTO:BTO_0006016,
CLO:CLO_0002125,
CLO:CLO_0002129,
EFO:EFO_0002122,
CLDB:cl521,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-1594,
ATCC:CRL-7396,
BioSample:SAMN03471401,
cancercelllines:CVCL_2253,
Cell_Model_Passport:SIDM00905,
Cosmic:687506,
Cosmic:877471,
Cosmic:925358,
Cosmic:928906,
Cosmic:1019308,
Cosmic:1131518,
Cosmic:1193035,
Cosmic:1201771,
Cosmic:2646656,
Cosmic:2660189,
Cosmic:2816213,
Cosmic-CLP:687506,
DepMap:ACH-001334,
ECACC:89051702,
EGA:EGAS00001000978,
GDSC:687506,
GEO:GSM113860,
GEO:GSM253295,
GEO:GSM675731,
GEO:GSM685438,
GEO:GSM1669639,
IGRhCellID:C4I,
LINCS_LDP:LCL-1301,
PharmacoDB:C4I_151_2019,
PRIDE:PXD030304,
Progenetix:CVCL_2253,
Wikidata:Q54799744 |
|
|
CVCL_2253 |
2026-07-25 04:22:28 |
0 |
HPAC
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_3517
|
Homo sapiens (Human)
|
Pancreatic adenocarcinoma
|
Characteristics: Established from a nude mouse xenograft (ATCC=CRL-2119)., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:15367885
PMID:20215515
PMID:20418756
PMID:22460905
PMID:22585861
PMID:25167228
PMID:25485619
PMID:25877200
PMID:25939163
PMID:25984343
PMID:26216984
PMID:26589293
PMID:27259358
PMID:27397505
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
Hpac |
|
|
BTO:BTO_0004121,
CLO:CLO_0003814,
EFO:EFO_0002197,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-2119,
BCRC:60495,
BioSample:SAMN03472247,
BioSample:SAMN10987698,
cancercelllines:CVCL_3517,
CCRID:1101HUM-PUMC000189,
Cell_Model_Passport:SIDM00670,
ChEMBL-Cells:CHEMBL3308388,
ChEMBL-Targets:CHEMBL612595,
CLS:305309,
Cosmic:913306,
Cosmic:1571784,
Cosmic:1995444,
Cosmic:2434094,
Cosmic-CLP:1298136,
DepMap:ACH-000270,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:1298136,
GEO:GSM206509,
GEO:GSM621897,
GEO:GSM784701,
GEO:GSM887089,
GEO:GSM888160,
GEO:GSM1024401,
GEO:GSM1374545,
GEO:GSM1669892,
IARC_TP53:21070,
IGRhCellID:HPAC,
LiGeA:CCLE_795,
LINCS_LDP:LCL-1735,
PharmacoDB:HPAC_564_2019,
PRIDE:PXD003198,
PRIDE:PXD030304,
PRIDE:PXD032263,
Progenetix:CVCL_3517,
PubChem_Cell_line:CVCL_3517,
Wikidata:Q54890226 |
|
|
CVCL_3517 |
2026-07-25 04:43:02 |
44 |
HH [Human lymphoma]
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1280
|
Homo sapiens (Human)
|
Primary cutaneous T-cell non-Hodgkin lymphoma
|
Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1879969
PMID:20164919
PMID:20215515
PMID:22460905
PMID:25355872
PMID:26589293
PMID:27397505
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:31160637
PMID:35839778
|
Cancer cell line
|
Male |
|
|
|
CLO:CLO_0003744,
EFO:EFO_0002194,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
ATCC:CRL-2105,
BCRC:60248,
BioSample:SAMN03472543,
BioSample:SAMN10987897,
cancercelllines:CVCL_1280,
Cell_Model_Passport:SIDM00671,
ChEMBL-Cells:CHEMBL3308142,
ChEMBL-Targets:CHEMBL2366310,
Cosmic:687843,
Cosmic:907056,
Cosmic:1551452,
Cosmic:2153071,
Cosmic:2402471,
Cosmic-CLP:907056,
DepMap:ACH-000061,
DSMZ:ACC-707,
DSMZCellDive:ACC-707,
EGA:EGAS00001000978,
GDSC:907056,
GEO:GSM887082,
GEO:GSM888152,
GEO:GSM1669882,
IARC_TP53:21371,
IGRhCellID:HH,
LiGeA:CCLE_426,
LINCS_LDP:LCL-1141,
PharmacoDB:HH_544_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1280,
PubChem_Cell_line:CVCL_1280,
Wikidata:Q54887334 |
|
|
CVCL_1280 |
2026-07-25 04:42:37 |
11 |
Ishikawa
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_2529
|
Homo sapiens (Human)
|
Type I endometrial adenocarcinoma
|
Miscellaneous: DepMap data are indicated for Ishidisconkawa (Heraklio) 02 ER- (CVCL_6543), but the referenced ECACC provider corresponds to Ishikawa (CVCL_2529)., Population: Japanese., Part of: ENCODE project common cell types; tier 3.
|
PMID:4031568
PMID:10381137
PMID:12703541
PMID:15053063
PMID:15901131
PMID:20215515
PMID:20218740
PMID:20944090
PMID:22710073
PMID:23255909
PMID:25877200
PMID:27397505
PMID:36396974
|
Cancer cell line
|
Female |
ISHIKAWA, ISHI |
|
|
BTO:BTO_0003041,
CLO:CLO_0037163,
EFO:EFO_0005718,
ArrayExpress:E-MTAB-3610,
BCRJ:0364,
BioSample:SAMN03471030,
cancercelllines:CVCL_2529,
CCRID:1101HUM-PUMC000686,
Cell_Model_Passport:SIDM00038,
ChEMBL-Cells:CHEMBL3307675,
ChEMBL-Targets:CHEMBL614649,
CLS:305262,
Cosmic:713475,
Cosmic:713499,
Cosmic:809129,
Cosmic:846174,
Cosmic:1070811,
Cosmic:1152553,
Cosmic:1176597,
Cosmic:1177618,
Cosmic:1241344,
Cosmic:1622902,
Cosmic:1696753,
Cosmic:2030475,
Cosmic:2464666,
Cosmic:2646616,
Cosmic:2702440,
DepMap:ACH-000961,
ECACC:99040201,
EGA:EGAS00001000978,
ENCODE:ENCBS228AAA,
ENCODE:ENCBS229AAA,
ENCODE:ENCBS230AAA,
GEO:GSM374972,
GEO:GSM375431,
GEO:GSM827370,
GEO:GSM1008593,
GEO:GSM1008594,
GEO:GSM1669941,
GEO:GSM3161714,
GEO:GSM3161715,
GEO:GSM6421758,
GEO:GSM6421759,
GEO:GSM6421760,
GEO:GSM6421769,
GEO:GSM6421770,
GEO:GSM6421771,
GEO:GSM6421772,
GEO:GSM6421773,
GEO:GSM6421774,
GEO:GSM6421775,
GEO:GSM6421776,
GEO:GSM6727286,
GEO:GSM6727287,
IARC_TP53:1112,
LINCS_HMS:50018,
LINCS_LDP:LCL-1497,
PharmacoDB:Ishikawa_667_2019,
Progenetix:CVCL_2529,
PubChem_Cell_line:CVCL_2529,
TOKU-E:3966,
Ubigene:YC-D023,
Wikidata:Q54898281 |
|
|
CVCL_2529 |
2026-07-25 04:46:59 |
35 |
IST-Mes1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1311
|
Homo sapiens (Human)
|
Pleural epithelioid mesothelioma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10232421
PMID:20164919
PMID:22460905
PMID:27397505
PMID:30894373
PMID:31068700
PMID:31395879
PMID:35839778
|
Cancer cell line
|
Female |
IST-MES1, IST-MES-1, ISTMES1, Istituto Scientifico Tumori-Mesothelioma 1 |
|
|
CLO:CLO_0006972,
CLDB:cl5540,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN10987671,
cancercelllines:CVCL_1311,
Cell_Model_Passport:SIDM00224,
ChEMBL-Cells:CHEMBL3308291,
ChEMBL-Targets:CHEMBL2366194,
Cosmic:907173,
Cosmic:1995456,
Cosmic-CLP:907173,
DepMap:ACH-000569,
EGA:EGAS00001000978,
GDSC:907173,
GEO:GSM887165,
GEO:GSM888237,
GEO:GSM1669943,
IARC_TP53:21399,
ICLC:HTL01005,
LiGeA:CCLE_714,
LINCS_LDP:LCL-1228,
PharmacoDB:ISTMES1_670_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1311,
PubChem_Cell_line:CVCL_1311,
Wikidata:Q54898347 |
|
|
CVCL_1311 |
2026-07-25 04:47:01 |
1 |
IST-SL2
Resource Report
Resource Website
|
RRID:CVCL_1314
|
Homo sapiens (Human)
|
Lung small cell carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:20164919
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
IST SL2, ISTSL2, Istituto Scientifico Tumori-Small cell Lung 2 |
|
|
CLO:CLO_0006975,
CLDB:cl2909,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
cancercelllines:CVCL_1314,
Cell_Model_Passport:SIDM00230,
ChEMBL-Cells:CHEMBL3308871,
ChEMBL-Targets:CHEMBL2366101,
Cosmic:753565,
Cosmic:1995458,
Cosmic-CLP:753565,
DepMap:ACH-002145,
EGA:EGAS00001000978,
GDSC:753565,
GEO:GSM1669945,
IARC_TP53:21400,
ICLC:HTL97010,
LINCS_LDP:LCL-1869,
PharmacoDB:ISTSL2_673_2019,
PRIDE:PXD030304,
PubChem_Cell_line:CVCL_1314,
Wikidata:Q54898351 |
|
|
CVCL_1314 |
2026-07-25 04:47:01 |
0 |
IST-Mes1
Resource Report
Resource Website
1+ mentions
|
ICLC Cat# HTL01005, RRID:CVCL_1311
|
Homo sapiens (Human)
|
Pleural epithelioid mesothelioma
|
Population: Caucasian., Part of: TCGA-110-CL cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:10232421
PMID:20164919
PMID:22460905
PMID:27397505
PMID:30894373
PMID:31068700
PMID:31395879
PMID:35839778
|
Cancer cell line
|
Female |
IST-MES1, IST-MES-1, ISTMES1, Istituto Scientifico Tumori-Mesothelioma 1 |
ICLC |
HTL01005 |
CLO:CLO_0006972,
CLDB:cl5540,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN10987671,
cancercelllines:CVCL_1311,
Cell_Model_Passport:SIDM00224,
ChEMBL-Cells:CHEMBL3308291,
ChEMBL-Targets:CHEMBL2366194,
Cosmic:907173,
Cosmic:1995456,
Cosmic-CLP:907173,
DepMap:ACH-000569,
EGA:EGAS00001000978,
GDSC:907173,
GEO:GSM887165,
GEO:GSM888237,
GEO:GSM1669943,
IARC_TP53:21399,
ICLC:HTL01005,
LiGeA:CCLE_714,
LINCS_LDP:LCL-1228,
PharmacoDB:ISTMES1_670_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1311,
PubChem_Cell_line:CVCL_1311,
Wikidata:Q54898347 |
|
|
CVCL_1311 |
2026-07-25 04:47:01 |
1 |
JAR
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_0360
|
Homo sapiens (Human)
|
Gestational choriocarcinoma
|
Caution: Established from the trophoblastic tumor of the placenta of a 24 year old woman, but the cell line is from the male fetus., Karyotypic information: Near triploid karyotype (PubMed=33096371)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:2720636
PMID:2878840
PMID:3518877
PMID:4038916
PMID:7153601
PMID:7716126
PMID:7819056
PMID:7937597
PMID:20164919
PMID:20215515
PMID:24098444
PMID:27397505
PMID:28161053
PMID:28534963
PMID:28724925
PMID:30894373
PMID:33096371
PMID:35839778
|
Cancer cell line
|
Male |
Jar, JAr, JaR |
|
|
BTO:BTO_0001585,
CLO:CLO_0007011,
EFO:EFO_0002211,
MCCL:MCC:0000254,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-144,
BCRC:60491,
BioSample:SAMN01821568,
BioSample:SAMN01821637,
BioSample:SAMN03472717,
cancercelllines:CVCL_0360,
CCRID:3101HUMTCHu156,
Cell_Model_Passport:SIDM01039,
ChEMBL-Cells:CHEMBL3307657,
ChEMBL-Targets:CHEMBL614587,
CLS:300221,
Cosmic:907175,
Cosmic:2077193,
Cosmic-CLP:907175,
DepMap:ACH-001529,
DSMZ:ACC-462,
DSMZCellDive:ACC-462,
EGA:EGAS00001000978,
GDSC:907175,
GEO:GSM827264,
GEO:GSM1669947,
IARC_TP53:21417,
IGRhCellID:JAR,
IZSLER:BS TCL 182,
KCLB:30144,
LINCS_LDP:LCL-1491,
PharmacoDB:JAR_676_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0360,
PubChem_Cell_line:CVCL_0360,
TOKU-E:2064,
Wikidata:Q54898511 |
|
|
CVCL_0360 |
2026-07-25 04:47:05 |
7 |
JEG-3
Resource Report
Resource Website
100+ mentions
|
BCRC Cat# 60428, RRID:CVCL_0363
|
Homo sapiens (Human)
|
Gestational choriocarcinoma
|
Caution: A TP53 mutation is indicated as being at p.Gln167His (c.501G>T) in PubMed=7819056 but has not been confirmed by CCLE and Cosmic-CLP., Karyotypic information: Near tetraploid karyotype (PubMed=33096371)., Characteristics: Established by serial cloning into hamster cheek pouches., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62839
PMID:327080
PMID:833871
PMID:2878840
PMID:3518877
PMID:5103722
PMID:6220172
PMID:7459858
PMID:7753552
PMID:7819056
PMID:7937597
PMID:11994546
PMID:12966428
PMID:16797695
PMID:20164919
PMID:20215515
PMID:27397505
PMID:28161053
PMID:28724925
PMID:30894373
PMID:33096371
PMID:33810901
PMID:35839778
|
Cancer cell line
|
Male |
Jeg-3, JEG3, Jeg3, jeg3 |
BCRC |
60428 |
BTO:BTO_0002269,
CLO:CLO_0007017,
EFO:EFO_0002066,
MCCL:MCC:0000257,
CLDB:cl2935,
CLDB:cl2936,
ABM:T8976,
AddexBio:C0030003/4940,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-36,
BCRC:60428,
BCRJ:0123,
BioSample:SAMN01821538,
BioSample:SAMN01821638,
cancercelllines:CVCL_0363,
CCRID:1101HUM-PUMC000071,
CCRID:3101HUMTCHu195,
CCRID:4201HUM-CCTCC00320,
CCTCC:GDC0320,
Cell_Model_Passport:SIDM01218,
ChEMBL-Cells:CHEMBL3308202,
ChEMBL-Targets:CHEMBL2366348,
CLS:300222,
Cosmic:683654,
Cosmic:907176,
Cosmic:1312288,
Cosmic:2077192,
Cosmic-CLP:907176,
DepMap:ACH-001530,
DSMZ:ACC-463,
DSMZCellDive:ACC-463,
ECACC:92120308,
EGA:EGAS00001000978,
GDSC:907176,
GEO:GSM48266,
GEO:GSM48267,
GEO:GSM48268,
GEO:GSM1669948,
IARC_TP53:4344,
IARC_TP53:21418,
IGRhCellID:JEG3,
IZSLER:BS TCL 181,
KCLB:30036,
LINCS_LDP:LCL-1492,
NCBI_Iran:C544,
PharmacoDB:JEG3_677_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0363,
PubChem_Cell_line:CVCL_0363,
TOKU-E:2070,
Wikidata:Q54898563 |
|
|
CVCL_0363 |
2026-07-25 04:47:06 |
384 |
JEG-3
Resource Report
Resource Website
100+ mentions
|
CCTCC Cat# GDC0320, RRID:CVCL_0363
|
Homo sapiens (Human)
|
Gestational choriocarcinoma
|
Caution: A TP53 mutation is indicated as being at p.Gln167His (c.501G>T) in PubMed=7819056 but has not been confirmed by CCLE and Cosmic-CLP., Karyotypic information: Near tetraploid karyotype (PubMed=33096371)., Characteristics: Established by serial cloning into hamster cheek pouches., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:62839
PMID:327080
PMID:833871
PMID:2878840
PMID:3518877
PMID:5103722
PMID:6220172
PMID:7459858
PMID:7753552
PMID:7819056
PMID:7937597
PMID:11994546
PMID:12966428
PMID:16797695
PMID:20164919
PMID:20215515
PMID:27397505
PMID:28161053
PMID:28724925
PMID:30894373
PMID:33096371
PMID:33810901
PMID:35839778
|
Cancer cell line
|
Male |
Jeg-3, JEG3, Jeg3, jeg3 |
CCTCC |
GDC0320 |
BTO:BTO_0002269,
CLO:CLO_0007017,
EFO:EFO_0002066,
MCCL:MCC:0000257,
CLDB:cl2935,
CLDB:cl2936,
ABM:T8976,
AddexBio:C0030003/4940,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-36,
BCRC:60428,
BCRJ:0123,
BioSample:SAMN01821538,
BioSample:SAMN01821638,
cancercelllines:CVCL_0363,
CCRID:1101HUM-PUMC000071,
CCRID:3101HUMTCHu195,
CCRID:4201HUM-CCTCC00320,
CCTCC:GDC0320,
Cell_Model_Passport:SIDM01218,
ChEMBL-Cells:CHEMBL3308202,
ChEMBL-Targets:CHEMBL2366348,
CLS:300222,
Cosmic:683654,
Cosmic:907176,
Cosmic:1312288,
Cosmic:2077192,
Cosmic-CLP:907176,
DepMap:ACH-001530,
DSMZ:ACC-463,
DSMZCellDive:ACC-463,
ECACC:92120308,
EGA:EGAS00001000978,
GDSC:907176,
GEO:GSM48266,
GEO:GSM48267,
GEO:GSM48268,
GEO:GSM1669948,
IARC_TP53:4344,
IARC_TP53:21418,
IGRhCellID:JEG3,
IZSLER:BS TCL 181,
KCLB:30036,
LINCS_LDP:LCL-1492,
NCBI_Iran:C544,
PharmacoDB:JEG3_677_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0363,
PubChem_Cell_line:CVCL_0363,
TOKU-E:2070,
Wikidata:Q54898563 |
|
|
CVCL_0363 |
2026-07-25 04:47:06 |
384 |
